Global Heparin Market by Product (Low Molecular Weight Heparin (LMWH), Ultra-low Molecular Weight Heparin (ULMWH)), by Application (Venous Thromboembolism, Coronary Artery Disease, Atrial Fibrillation, Others), by Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) by Route of Administration (Intravenous, Subcutaneous), and by Region (North America, Europe, Asia Pacific, Latin America, MEA), - Global Forecasts 2017 to 2027

The Global Heparin Market was valued at USD 6.5 billion in 2020 and is expected to reach USD 9.7 billion by 2027, growing at a CAGR of 5.9% during the forecast period, 2021 - 2027

Heparin also termed unfractionated heparin (UFH) is a naturally occurring glycosaminoglycan. It is applied as an anticoagulant in drugs. It is especially useful during the treatment of heart attacks or unstable angina. It is injected into a vein or under the skin. It is also employed for cardiopulmonary bypass and blood filtration during cardiac operation, including for a variety of health problems including acute coronary syndrome, deep vein thrombosis, pulmonary embolism, atrial fibrillation, and more. Its application extends to the management of major orthopedic surgeries, such as hip and knee arthroplasty.

Heparin Market

Key Highlights of Heparin Market

The market is majorly driven by the increasing prevalence of chronic diseases such as acute coronary syndrome, deep vein thrombosis, pulmonary embolism, atrial fibrillation, and more. Moreover, beneficiary government initiatives for the pharmaceutical industry are propelling the market growth. However, availability of alternative drugs in such sector and high degree of consolidation making entry of small players difficult is hampering the market growth in forecast period.

The Global Heparin Industry Segmentation:

  • By Product Type
    • Low Molecular Weight Heparin (LMWH)
    • Ultra-low Molecular Weight Heparin (ULMWH)
  • By Application
    • Venous Thromboembolism
    • Coronary Artery Disease
    • Atrial Fibrillation
    • Others
  • By Distribution Channel
    • Hospital Pharmacies
    • Drug Stores & Retail Pharmacies
    • Online Pharmacies
  • By Route of Administration
    • Intravenous
    • Subcutaneous
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Company Profiles and Competitive Intelligence

The key players operating in the market are:

  • Baxter International Inc.
  • B. Braun Holding GmbH & Co. KG
  • Dr. Reddy’s Laboratories Ltd.
  • Fresenius SE & Co KGaA
  • Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
  • Leo Pharma A/S
  • Pfizer Inc.
  • Sanofi S.A
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • GlaxoSmithKline plc
  • Aspen Holdings
  • Emcure Pharmaceutical Pvt. Ltd.
  • Cipla Ltd.
  • Bharat Serum
  • Abbott Laboratories
  • Lupin Ltd.
  • Intas Pharmaceuticals Ltd.
  • Samarth Life Sciences Pvt. Ltd.
  • Claris Lifesciences Limited
  • Gland Pharma Limited
  • Mylan Pharmaceutical
  • Torrent Pharmaceuticals
  • Micro Labs Ltd. 
  • Troikaa Pharmaceuticals Ltd.
  • Biological E Limited
  • VHB Life Sciences Limited
  • Celon Laboratories Pvt. Ltd.
  • United Biotech (P) Limited

The unique insights provided by this report also include the following:

  1. In-depth value chain analysis
  2. Opportunity mapping
  3. Sector snapshot
  4. Key Players Positioning Matrix
  5. Regulatory scenario
  6. Strategies Adopted-Benchmarking Heat Map
  7. Market trends
  8. Covid-19 impact analysis
  9. Product comparison
  10. Pre & Post COVID 19 impact on Heparin Market
  11. Competitive Landscape

Based on Product, the Low Molecular Weight Heparin (LMWH) type segment is expanding at a high growth rate during the period 2021-2027.

The Low Molecular Weight Heparin (LMWH) segment is anticipated to hold the largest market share in forecast period. This is owing to the fact that its effects on the patients and the drugs are more predictable. Moreover, the low occurrence of heparin induced thrombocytopenia is propelling the market growth.

Based on the application, the coronary artery disease segment accounted for the largest share in the overall Heparin market size.

Among all the applications, the coronary artery diseases segment is dominating the market. The dominance is expected to continue throughout the forecast period owing to the growing incidences and prevalence of heart related disorders. Additionally, the venous thromboembolism (VTE) segment is anticipated to grow with the highest CAGR in the forecast period owing to the increasing mortality rate from venous thromboembolism and rising awareness about thrombosis is driving the market growth.

Based on regions, the market for Heparin in North America accounted for the largest share in 2020, followed by Asia Pacific and Europe.

Geographically, the North American region is holding the largest market shares in terms of volume. The dominance is attributed to factors such as growing prevalence of cardiovascular disorders and rising incidences of sports injuries. Additionally, high patient awareness, high healthcare expenditure, and advanced healthcare infrastructure are propelling the market growth. Moreover, the Asia Pacific region is also anticipated to show highest growth rate in the forecast period. Factors responsible may include, rapidly developing healthcare infrastructure, and increase in market players in both private and public sector.

The report also provides in-depth analysis of Heparin market dynamics such as drivers, restraints opportunities and challenges


  • Increasing Occurrence of Diseases
  • Beneficial Government Initiatives for the Pharmaceutical Industry


  • High Degree of Consolidation to Hinder Small Players From Entering the Market
  • Availability of Alternative Drugs


  • Unfavourable Regulatory and Pricing Issues

COVID-19 Impact on the Heparin Market Analysis

The impact of COVID-19 has greatly affected the market of the Heparin industry. Apart from the fact that this epidemic has emerged as a threat to both human lives and to economic activities worldwide. However, the COVID-19 outbreak has brought the increased prevalence of several respiratory disorders or respiratory tract infections leading to more usage of heparin injections to prevent blood clots for those who are at high risks of blood clot formation, therefore driving the heparin market in the forecast period.

The report also provides an in-depth analysis of key trends in the Heparin market

Sr. No. Trends Impact
1 The outbreak of COVID-19 has brought a critical situation for healthcare industry. The heparin injections are useful in many surgeries and respiratory disorders to prevent blood clots Positive
2 The increasing number of patients suffering with chronic diseases  Positive
3 Supportive government initiatives for the pharmaceutical industry  Positive

The report also provides in-depth analysis of recent news developments and investments

  1. In April 2021, Pfizer Inc. announced that it have completed its 100% acquitance over Amplyx Pharmaceuticals, Inc., a privately held U.S. based company. This acquisition would help both the companies to create its market base in this epidemic crisis.
  2. In February 2019, Fresenius Medical Care announced its successful acquisition over NxStage Medical, Inc. (NxStage). This acquisition was approved by antitrust authorities in the United States and will help Fresenius Medical Care group in leveraging its manufacturing and rendering business across the United States.
  3. In August 2018, Danish LEO Pharma acquired the Bayer’s global prescription dermatology business. This transaction was made worth of approximately USD 1 billion. LEO Pharma aimed to help 125 million patients by 2025 and further cement its position in the derma-market with the help of this acquisition.

Frequently Asked Questions (FAQs)

The global Heparin market was valued at US$ 6.5 Bn in 2020 and is anticipated to reach US$ 9.7 Bn by 2027.

The Heparin market is estimated to grow at a compound annual growth rate (CAGR) of 5.9% during 2021-2027.

A few key players include, but not limited to: Baxter International Inc., B. Braun Holding GmbH & Co. KG, Dr. Reddy’s Laboratories Ltd., Fresenius SE & Co KGaA, Hebei Changshan Biochemical Pharmaceutical Co., Ltd., Leo Pharma A/S, Pfizer Inc., Sanofi S.A, Teva Pharmaceutical Industries Ltd., Viatris Inc., GlaxoSmithKline plc, and Aspen Holdings.

Related Reports

Need specific market information ?

Ask for free product review call with the author

Share your specific research requirements for a customized report

Request for due diligence and consumer centric studies

Request for study updates, segment specific and country level reports

    1. Product Outline
    2. What is Heparin
    3. Different types of Heparin  
    4. Analysis of Heparin  Ecosystem
    5. Supply Chain Analysis
    6. Covid -19 Impact
    7. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Threats
    8. Production Overview
    9. Patent Analysis
  2. Regulatory Landscape for Heparin    
    1. Regulations and Standards
  3. Heparin  Market Pricing Analysis
    1. Prices of Heparin   
  4. Heparin  Market by Product
    1. Low Molecular Weight Heparin (LMWH)
    2. Ultra-low Molecular Weight Heparin (ULMWH)
  5. Heparin  Market  by Application
    1. Venous Thromboembolism
    2. Coronary Artery Disease
    3. Atrial Fibrillation
    4. Others
  6. Heparin  Market  by Distribution Channel
    1. Hospital Pharmacies
    2. Drug Stores & Retail Pharmacies
    3. Online Pharmacies
  7. Heparin  Market by Route of Administration
    1. Intravenous
    2. Subcutaneous
  8. Regional Analysis
    1. North America
      1. US
      2. Canada
      3. Mexico
    2. Europe
      1. Germany
      2. UK
      3. France
      4. Norway
      5. Italy
      6. Spain
      7. Netherlands
      8. Rest Of Europe
    3. Asia Pacific
      1. China
      2. India
      3. Japan
      4. Australia
      5. Rest Of Asia Pacific
    4. Middle East and Africa
    5. South America
  9. Key Strategic Insights
    1. New Raw Material Sources
    2. New Applications
    3. Opportunity mapping
    4. Critical Success Factors
    5. Environmental Impact and sustainability issues
    6. Consumer Preferences
  10. Key Market Trends / Recent Developments
  11. Competitive Scenario
    1. Competitive Strategies of Key Players
      1. Mergers and Acquisitions
      2. Investments
      3. Joint Ventures
      4. New Product launches
    2. Ranking of Key Players
    1. Baxter International Inc.
    2. B. Braun Holding GmbH & Co. KG
    3. Dr. Reddy’s Laboratories Ltd.
    4. Fresenius SE & Co KGaA
    5. Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
    6. Leo Pharma A/S
    7. Pfizer Inc.
    8. Sanofi S.A
    9. Teva Pharmaceutical Industries Ltd.
    10. Viatris Inc.
    11. GlaxoSmithKline plc
    12. Aspen Holdings

Choose License

License Type
Ask for Customization

Why Choose AllTheResearch?

  • Monthly market updates for 6 months
  • Online access of reports
  • Options to buy sections of report
  • Critically analysed research on Quadrant Positioning of your company.
  • Syndicated report along with a supplementary report with objective-based study
  • Get profiled in the reports.Expanding your visibility across our network of readers and viewers
  • We provide local market data in local language on request
  • A complementary co-branded white paper
  • Flat consulting fee based exclusive studies. Consult at the price of syndicate
  • Access to expert team for free transaction advisory service.
Speak to Analyst

Quick Inquiry

Follow Us

Choose License

License Type
Ask for Customization